Merriman Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Merriman Wealth Management, LLC

$2.3 Billion
Q4 2024

A detailed history of Merriman Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Merriman Wealth Management, LLC holds 3,705 shares of BMY stock, worth $199,699. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,705

Holding current value

$199,699

% of portfolio

0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$51.92 - $59.94 $192,363 - $222,077	3,705 New	3,705 $209,000
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $197,821 - $224,291	4,123 New	4,123 $223,000
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $2,484 - $2,758	39 Added 1.07%	3,700 $236,000
Q1 2023 May 04, 2023	SELL	$65.71 - $74.53 $4,074 - $4,620	-62 Reduced 1.67%	3,661 $253,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $15,065 - $17,839	220 Added 6.28%	3,723 $267,000
Q3 2022 Oct 26, 2022	SELL	$0.13 - $76.84 $0 - $76	-1 Reduced 0.03%	3,503 $249,000
Q2 2022 Jul 29, 2022	SELL	$72.62 - $79.98 $13,943 - $15,356	-192 Reduced 5.19%	3,504 $269,000
Q1 2022 Apr 28, 2022	BUY	$61.48 - $73.72 $21,518 - $25,802	350 Added 10.46%	3,696 $270,000
Q4 2021 Feb 01, 2022	BUY	$53.63 - $62.52 $4,612 - $5,376	86 Added 2.64%	3,346 $209,000
Q4 2021 Feb 01, 2022	BUY	$53.63 - $62.52 $174,833 - $203,815	3,260 New	3,260 $218,000
Q3 2021 Nov 09, 2021	SELL	$59.17 - $69.31 $192,894 - $225,950	-3,260 Closed	0 $0
Q2 2021 Jul 28, 2021	SELL	$61.91 - $67.42 $619 - $674	-10 Reduced 0.31%	3,260 $218,000
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $74,412 - $83,691	-1,254 Reduced 27.72%	3,270 $206,000
Q4 2020 Feb 10, 2021	BUY	$57.74 - $65.43 $58,548 - $66,346	1,014 Added 28.89%	4,524 $281,000
Q3 2020 Oct 26, 2020	SELL	$57.43 - $63.64 $9,016 - $9,991	-157 Reduced 4.28%	3,510 $212,000
Q2 2020 Jul 31, 2020	SELL	$54.82 - $64.09 $50,105 - $58,578	-914 Reduced 19.95%	3,667 $216,000
Q1 2020 Apr 22, 2020	SELL	$46.4 - $67.43 $18,560 - $26,972	-400 Reduced 8.03%	4,581 $255,000
Q4 2019 Jan 23, 2020	BUY	$49.21 - $64.19 $37,694 - $49,169	766 Added 18.17%	4,981 $320,000
Q3 2019 Oct 18, 2019	BUY	$42.77 - $50.71 $180,275 - $213,742	4,215 New	4,215 $214,000
Q4 2018 Jan 28, 2019	SELL	$48.76 - $63.23 $188,116 - $243,941	-3,858 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$55.19 - $62.25 $386 - $435	7 Added 0.18%	3,858 $240,000
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $26,932 - $33,568	-533 Reduced 12.16%	3,851 $213,000
Q1 2018 Apr 10, 2018	BUY	$59.92 - $68.98 $262,689 - $302,408	4,384 New	4,384 $277,000
Q4 2017 Feb 05, 2018	SELL	$59.94 - $65.35 $206,373 - $225,000	-3,443 Closed	0 $0
Q3 2017 Oct 19, 2017	BUY	$55.23 - $63.74 $190,156 - $219,456	3,443	3,443 $219,000

Others Institutions Holding BMY

# of Institutions

2,729

Shares Held

1.57B

Call Options Held

30M

Put Options Held

31.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Merriman Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Merriman Wealth Management, LLC with notifications on news.

Account

Merriman Wealth Management, LLC Bristol Myers Squibb CO Transaction History